Paul J Sekhri's Net Worth
Estimate Recalculated Apr 21, 2025 12:25PM EST
Who is Paul J Sekhri
Paul J Sekhri has an estimated net worth of $11.2 Million. This is based on reported shares across multiple companies, which include VEEVA SYSTEMS INC, Enumeral Biomedical Holdings, Inc., ARYx Therapeutics, Inc., Biodel Inc, Nivalis Therapeutics, Inc., Longboard Pharmaceuticals, Inc., BiomX Inc., vTv Therapeutics Inc., Axcella Health Inc., and ARIAD PHARMACEUTICALS INC.
SEC CIK
Paul J Sekhri's CIK is 0001264519
Past Insider Trading and Trends
2021 was Paul J Sekhri's most active year for acquiring shares with 9 total transactions. Paul J Sekhri's most active month to acquire stocks was the month of May. 2018 was Paul J Sekhri's most active year for disposing of shares, totalling 15 transactions. Paul J Sekhri's most active month to dispose stocks was the month of November. 2024 saw Paul J Sekhri paying a total of $1,053,593.72 for 113,936 shares, this is the most they've acquired in one year. In 2022 Paul J Sekhri cashed out on 12,706 shares for a total of $2,354,254.10, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
